Iovance Biotherapeutics Inc (IOVA)

[badgerkid]

MNGopher, the latest approval is for a very specific and small segment of lung cancer, small cell. Iovance and TIL therapy is targeting non-small cell lung cancer with its over 230,000+ new cases of nsclc in the U.S. each year. Amgen's new drug is also dealing with some very serious side effects. With that said, it may buy time for that portion of patients that are months away from dying. TIL therapy will still prove to be a significantly better option for many if not most of the NSCLC patients but as of yet we don't know what it will do for Small Cell Lung Cancer. TIL still appears to be the future treatment for many solid tumor cancers, but there are so many genetic variables that still have to be worked out that anything right now that offers some hope to even a handful is a step hopefully forward until TIL gets approval.

If anyone can offer more detail right now regarding Amgen's new drug, it would be appreciated, but I still understand that TIL therapy and all its future improvements over the coming years and decades offers far more hope for a much larger portion of all solid tumor cancers.